We are fascinated by elegant and disruptive medical technologies addressing clear medical needs. We had a long history in backing companies in cardiovascular diseases, neurological disorders and oncology. We love science. And we love devices. We look for powerful claims and smart clinical plans and we strive to continously improving them. We speak the languages of physicians, engineers and IP lawyers. We work with entrepreneurs in the pursuit of meaningful clinical breakthrough, the one and only driver of long term value creation in life sciences
HEALTHCARE PORTFOLIO
Bone substitute material, targeting regeneration in large gap non-union fractures, spine fusion and other indications
View Website - Read Contents
AI based platform technology for monitoring and treatment of neurological chronic diseases, starting with the Epilepsy market
View Website
Ablation catheter for Atrial Fibrillation with a navigation system based on miniaturized Optical Coherence Tomography technology
View Website - Read Contents
Next generation micro-catheter expected to be more efficient for brain thrombectomies than any other ischemic acute stroke treatment
View Website - Read Contents
Venture building facility focused on cardiovascular projects
View Website - Read Contents
Medical device for loco-regional radiation therapy for unresectable solid tumors treatment
View Website - Read Contents
Restoring brain and body functions with devices based on its large knowledge on biosignal decoding
View Website - Read Contents
Low profile transcatheter device for the treatment of aortic stenosis
View Website
Injection system to perform CO2-based angiography able to minimize patient pain and injection risks
View Website - Read Contents
Best-in-class one-shot ablation catheter for atrial fibrillation treatment
Drug delivery platform based on the use of patients’ erythrocytes as a vehicle for drugs and other molecules
View Website - Read Contents
Developing transformative gene therapy‑based treatments for cardiovascular disease
View Website - Read Contents
Innovative approach to treating cutaneous and sub-cutaneous tumours via the technique of clinical electroporation and electrochemotherapy
View Website
Micro/nanotechnology platform that prevents counterfeiting and grey-market product diversion across a broad range of industries
Set of solutions in the field of lab-on-a-chip technologies, targeted at miniaturized cell-biology testing for oncology and pre-natal analysis applications. Sold to Menarini in 2013
View Website
INVESTMENT TEAM
Johann Tse
Partner
Hadi Abderrahim
Partner
Hiroaki Tanaka
Partner
Claudio Giuliano
CEO
Claudio Rumazza
Partner
Giovanni Leo
Partner
VENTURE PARTNERS
Riccardo Palmisano
Healthcare Venture Partner
Simona Roggero
Healthcare Venture Partner
William R. Brody
US Venture Partner
Franco Rutili
Healthcare Venture Partner
Andrea Venturelli
Healthcare Venture Partner
Marta Antonucci
Healthcare Venture Partner
Paolo Cremascoli
Healthcare Venture Partner
